Heparan sulfate proteoglycans mediate factor XIIa binding to the cell surface

Journal of Biological Chemistry

Volumn 290, Issue 11, 2015, Pages 7027-7039

  Wujak, Lukasz ^a   Didiasova, Miroslava ^a   Zakrzewicz, Dariusz ^a   Frey, Helena ^b   Schaefer, Liliana ^b   Wygrecka, Malgorzata ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL MEMBRANES; CELLS; ENZYME ACTIVITY; FIBROBLASTS; GLYCOPROTEINS; SULFUR COMPOUNDS;

BINDING CAPACITIES; COAGULATION PATHWAY; HEPARAN SULFATE PROTEOGLYCANS; HUMAN LUNG FIBROBLASTS; IDIOPATHIC PULMONARY FIBROSIS; LOCAL ACCUMULATIONS; PREFERENTIAL BINDING; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

CYTOLOGY;

ANTISENSE OLIGONUCLEOTIDE; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 12A; CELL SURFACE RECEPTOR; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; DERMATAN SULFATE; DEXTRAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN LYASE; PROTEOHEPARAN SULFATE; RNA; SYNDECAN 1; UROKINASE; PROTEIN BINDING;

ARTICLE; CELL CULTURE; CELL FREE SYSTEM; CELL ISOLATION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CELLS BY BODY ANATOMY; CONTROLLED STUDY; FIBROGENESIS; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; KALLIKREIN KININ SYSTEM; LUNG FIBROBLAST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RNA INTERFERENCE; SULFATION; WESTERN BLOTTING; FIBROBLAST; LUNG; LUNG FIBROSIS; METABOLISM; PATHOLOGY;

CELLS, CULTURED; FACTOR XIIA; FIBROBLASTS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; LUNG; PROTEIN BINDING; PULMONARY FIBROSIS;

EID: 84924787549     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.606343     Document Type: Article

References (48)

1. Stavrou, E., and Schmaier, A. H. (2010) Factor XII: What does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. Thromb. Res. 125, 210-215
2. Ghebrehiwet, B., Lim, B. L., Peerschke, E. I., Willis, A. C., and Reid, K. B. (1994) Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J. Exp. Med. 179, 1809-1821
3. Renné, T., Schmaier, A. H., Nickel, K. F., Blombäck, M., and Maas, C. (2012) In vivo roles of factor XII. Blood 120, 4296-4303
4. Hojima, Y., Cochrane, C. G., Wiggins, R. C., Austen, K. F., and Stevens, R. L. (1984) In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E. Blood 63, 1453-1459
5. Oschatz, C., Maas, C., Lecher, B., Jansen, T., Björkqvist, J., Tradler, T., Sedlmeier, R., Burfeind, P., Cichon, S., Hammerschmidt, S., Müller-Esterl, W., Wuillemin, W. A., Nilsson, G., and Renné, T. (2011) Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. Immunity 34, 258-268
6. Pixley, R. A., Schmaier, A., and Colman, R. W. (1987) Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor. Arch. Biochem. Biophys. 256, 490-498
7. Henderson, L. M., Figueroa, C. D., Müller-Esterl, W., and Bhoola, K. D. (1994) Assembly of contact-phase factors on the surface of the human neutrophil membrane. Blood 84, 474-482
8. Schousboe, I. (2003) Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor. Eur. J. Biochem. 270, 111-118
9. Schousboe, I. (2001) Rapid and cooperative binding of factor XII to human umbilical vein endothelial cells. Eur. J. Biochem. 268, 3958-3963
10. Reddigari, S. R., Shibayama, Y., Brunné, T., and Kaplan, A. P. (1993) Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J. Biol. Chem. 268, 11982-11987
11. Mahdi, F., Madar, Z. S., Figueroa, C. D., and Schmaier, A. H. (2002) Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood 99, 3585-3596
12. Bradford, H. N., Pixley, R. A., and Colman, R. W. (2000) Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation. J. Biol. Chem. 275, 22756-22763
13. Ploug, M., Rahbek-Nielsen, H., Nielsen, P. F., Roepstorff, P., and Dano, K. (1998) Glycosylation profile of a recombinant urokinase-type plasminogen activator receptor expressed in Chinese hamster ovary cells. J. Biol. Chem. 273, 13933-13943
14. Jablonska, E., Markart, P., Zakrzewicz, D., Preissner, K. T., and Wygrecka, M. (2010) Transforming growth factor-β1 induces expression of human coagulation factor XII via Smad3 and JNK signaling pathways in human lung fibroblasts. J. Biol. Chem. 285, 11638-11651
15. Wygrecka, M., Marsh, L. M., Morty, R. E., Henneke, I., Guenther, A., Lohmeyer, J., Markart, P., and Preissner, K. T. (2009) Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 113, 5588-5598
16. Moreth, K., Frey, H., Hubo, M., Zeng-Brouwers, J., Nastase, M. V., Hsieh, L. T., Haceni, R., Pfeilschifter, J., Iozzo, R. V., and Schaefer, L. (2014) Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. Matrix Biol. 35, 143-151
17. Badellino, K. O., and Walsh, P. N. (2001) Localization of a heparin binding site in the catalytic domain of factor XIa. Biochemistry 40, 7569-7580
18. Wei, Z., Lyon, M., and Gallagher, J. T. (2005) Distinct substrate specificities of bacterial heparinases against N-unsubstituted glucosamine residues in heparan sulfate. J. Biol. Chem. 280, 15742-15748
19. Rostand, K. S., and Esko, J. D. (1997) Microbial adherence to and invasion through proteoglycans. Infect. Immun. 65, 1-8
20. Mali, M., Elenius, K., Miettinen, H. M., and Jalkanen, M. (1993) Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1. J. Biol. Chem. 268, 24215-24222
21. Lu, J., Auduong, L., White, E. S., and Yue, X. (2014) Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 50, 106-114
22. Ben-Zaken, O., Tzaban, S., Tal, Y., Horonchik, L., Esko, J. D., Vlodavsky, I., and Taraboulos, A. (2003) Cellular heparan sulfate participates in the metabolism of prions. J. Biol. Chem. 278, 40041-40049
23. Ai, X., Do, A. T., Lozynska, O., Kusche-Gullberg, M., Lindahl, U., and Emerson, C. P., Jr. (2003) QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J. Cell Biol. 162, 341-351
24. Sarrazin, S., Lamanna,W.C., and Esko, J. D. (2011) Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 10.1101/cshperspect.a004952
25. Xu, D., and Esko, J. D. (2014) Demystifying heparan sulfate-protein interactions. Annu. Rev. Biochem. 83, 129-157
26. Carter, W. J., Cama, E., and Huntington, J. A. (2005) Crystal structure of thrombin bound to heparin. J. Biol. Chem. 280, 2745-2749
27. Friedrich, U., Blom, A. M., Dahlbäck, B., and Villoutreix, B. O. (2001) Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C. J. Biol. Chem. 276, 24122-24128
28. Johnson, D. J., Langdown, J., and Huntington, J. A. (2010) Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-Å structure of the ternary complex. Proc. Natl. Acad. Sci. U.S.A. 107, 645-650
29. Pol-Fachin, L., and Verli, H. (2014) Structural glycobiology of heparin dynamics on the exosite 2 of coagulation cascade proteases: implications for glycosaminoglycans antithrombotic activity. Glycobiology 24, 97-105
30. Beringer, D. X., and Kroon-Batenburg, L. M. (2013) The structure of the FnI-EGF-like tandem domain of coagulation factor XII solved using SIRAS. Acta Crystallogr Sect. F Struct. Biol. Cryst. Commun. 69, 94-102
31. Ho, G., Broze, G. J., Jr., and Schwartz, A. L. (1997) Role of heparan sulfate proteoglycans in the uptake and degradation of tissue factor pathway inhibitor- coagulation factor Xa complexes. J. Biol. Chem. 272, 16838-16844
32. Shimada, K., and Ozawa, T. (1985) Evidence that cell surface heparan sulfate is involved in the high affinity thrombin binding to cultured porcine aortic endothelial cells. J. Clin. Invest. 75, 1308-1316
33. Kojima, T., Leone, C. W., Marchildon, G. A., Marcum, J. A., and Rosenberg, R. D. (1992) Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells. J. Biol. Chem. 267, 4859-4869
34. de Agostini, A. I., Watkins, S. C., Slayter, H. S., Youssoufian, H., and Rosenberg, R. D. (1990) Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: Antithrombin binding on cultured endothelial cells and perfused rat aorta. J. Cell Biol. 111, 1293-1304
35. Renné, T., Schuh, K., and Müller-Esterl, W. (2005) Local bradykinin formation is controlled by glycosaminoglycans. J. Immunol. 175, 3377-3385
36. Renné, T., Dedio, J., David, G., and Müller-Esterl, W. (2000) High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells. J. Biol. Chem. 275, 33688-33696
37. Renné, T., and Müller-Esterl, W. (2001) Cell surface-associated chondroitin sulfate proteoglycans bind contact phase factor H-kininogen. FEBS Lett. 500, 36-40
38. Coward, W. R., Saini, G., and Jenkins, G. (2010) The pathogenesis of idiopathic pulmonary fibrosis. Ther. Adv. Respir. Dis. 4, 367-388
39. Tager, A. M., LaCamera, P., Shea, B. S., Campanella, G. S., Selman, M., Zhao, Z., Polosukhin, V., Wain, J., Karimi-Shah, B. A., Kim, N. D., Hart, W. K., Pardo, A., Blackwell, T. S., Xu, Y., Chun, J., and Luster, A. D. (2008) The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat. Med. 14, 45-54
40. Sakai, N., and Tager, A. M. (2013) Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis. Biochim. Biophys. Acta. 1832, 911-921
41. Skandalis, S. S., Afratis, N., Smirlaki, G., Nikitovic, D., Theocharis, A. D., Tzanakakis, G. N., and Karamanos, N. K. (2014) Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: Focus on the role and impact of proteoglycans. Matrix Biol. 35, 182-193
42. Malavaki, C. J., Roussidis, A. E., Gialeli, C., Kletsas, D., Tsegenidis, T., Theocharis, A. D., Tzanakakis, G. N., and Karamanos, N. K. (2013) Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells. FEBS J. 280, 2477-2489
43. Gordon, E. M., Venkatesan, N., Salazar, R., Tang, H., Schmeidler-Sapiro, K., Buckley, S., Warburton, D., and Hall, F. L. (1996) Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase. Proc. Natl. Acad. Sci. U.S.A. 93, 2174-2179
44. LaRusch, G. A., Mahdi, F., Shariat-Madar, Z., Adams, G., Sitrin, R. G., Zhang, W. M., McCrae, K. R., and Schmaier, A. H. (2010) Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis. Blood 115, 5111-5120
45. Schmeidler-Sapiro, K. T., Ratnoff, O. D., and Gordon, E. M. (1991) Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells. Proc. Natl. Acad. Sci. U.S.A. 88, 4382-4385
46. Pucci, M., Fibbi, G., Magnelli, L., and Del Rosso, M. (2001) Regulation of urokinase/urokinase receptor interaction by heparin-like glycosaminoglycans. J. Biol. Chem. 276, 4756-4765
47. Afratis, N., Gialeli, C., Nikitovic, D., Tsegenidis, T., Karousou, E., Theocharis, A. D., Pavão,M. S., Tzanakakis, G. N., and Karamanos, N. K. (2012) Glycosaminoglycans: Key players in cancer cell biology and treatment. FEBS J. 279, 1177-1197
48. Thacker, B. E., Xu, D., Lawrence, R., and Esko, J. D. (2014) Heparan sulfate 3-O-sulfation: a rare modification in search of a function. Matrix Biol. 35, 60-72